Log In
BCIQ
Print this Print this
 

PXS TPI1100 (TPI 1100) (formerly TPI-PD3)

Also known as: TPI-1100 (formerly PD3)

  Manage Alerts
Collapse Summary General Information
Company Pharmaxis Ltd.
DescriptionPhosphodiesterase (PDE) inhibitor
Molecular Target Phosphodiesterase-4 (PDE-4) ; Phosphodiesterase-7 (PDE-7)
Mechanism of ActionPhosphodiesterase-4 (PDE-4) inhibitor; Phosphodiesterase-7 (PDE-7) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$20.6M

0

$12.6M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/15/2010

$20.6M

0

$12.6M

Get a free BioCentury trial today